Dopamine is involved in the antidepressant-like effect of allopregnanolone in the forced swimming test in female rats

Behavioural Pharmacology

Volumn 21, Issue 1, 2010, Pages 21-28

  D'Aquila, Paolo S ^a   Canu, Silvia ^a   Sardella, Marco ^b   Spanu, Caterina ^a   Serra, Gino ^a   Franconi, Flavia ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b Gentium SpA   (Italy)

Author keywords

Allopregnanolone; Depression; Dopamine; Forced swimming test; Neurosteroids; Rat

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALLOPREGNANOLONE ACETATE; DOPAMINE; DOPAMINE 2 RECEPTOR; RACLOPRIDE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DIESTRUS; DOPAMINERGIC TRANSMISSION; DRUG ACTIVITY; DRUG INHIBITION; DRUG RECEPTOR BINDING; ESTRUS; FEMALE; NONHUMAN; RAT; SWIMMING;

ANIMALS; ANTIDEPRESSIVE AGENTS; BENZAZEPINES; DEPRESSION; DIESTRUS; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ESTRUS; FEMALE; PREGNANOLONE; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SWIMMING;

EID: 74549191348     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32833470a7     Document Type: Article

References (59)

1. Alonso SJ, Castellano MA, Afonso D, Rodriguez M (1991). Sex differences in behavioral despair: relationships between behavioral despair and open field activity. Physiol Behav 49:69-72.
2. Amin Z, Mason GF, Cavus I, Krystal JH, Rothman DL, Epperson CN (2006). The interaction of neuroactive steroids and GABA in the development of neuro-psychiatric disorders in women. Pharmacol Biochem Behav 84:635-643.
3. Asakura W, Matsumoto K, Ohta H,Watanabe H (1994). Involvement of dopamine D2 receptor mechanism in the REM sleep deprivation-induced increase in swimming activity in the forced swimming test. Pharmacol Biochem Behav 48:43-46.
4. Baamonde A, Dauge V, Ruiz-Gayo M, Fulga IG, Turcaud S, Fournie-Zaluski MC, Roques BP (1992). Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation. Eur J Pharmacol 216:157-166.
5. Bernardi F, Pluchino N, Begliuomini S, Lenzi E, Palumbo M, Luisi M, Genazzini AR (2004). Disadaptive disorders in women: allopregnanolone, a sensitive steroid. Gynecol Endocrinol 19:344-353.
6. Borsini F, Lecci A, Mancinelli A, D'Aranno V, Meli A (1988). Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity. Eur J Pharmacol 148:301-307.
7. Cabrera RJ, Bregonzio C, Laconi M, Mampel A (2002). Allopregnanolone increase in striatal N-Methyl-D-aspartic acid evoked [3H] dopamine release is estrogen and progesterone dependent. Cell Mol Neurobiol 22:445-454.
8. Charalampopoulos I, Dermitzaki E, Vardouli L, Tsatsanis C, Stournaras C, Margioris AN, Gravanis A (2005). Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 146:3309-3318.
9. Consoli D, Fedotova J, Micale V, Sapronov NS, Drago F (2005). Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test). Eur J Pharmacol 520:100-107.
10. Contreras CM, Martinez-Mota L, Saavedra M (1988). Desipramine restricts estral cycle oscillations in swimming. Prog Neuropsychopharmacol Biol Psychiatry 22:1121-1128.
11. D'Aquila PS, Collu M, Pani L, Gessa GL, Serra G (1994). Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair test model of depression. Eur J Pharmacol 262:107-111.
12. D'Aquila PS, Collu M, Gessa GL, Serra G (2000). The role of dopamina in the mechanism of action of antidepressant drugs. Eur J Pharmacol 405: 365-373.
13. Detke MJ, Lucki I (1996). Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73:43-46.
14. Detke MJ, Rickels M, Lucki I (1995). Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepres-sants. Psychopharmacology 121:66-72.
15. Ebert D, Feistel H, Kaschka W, Barocka A, Pirner A (1994). Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation-preliminary results. Biol Psychiatry 35:880-885.
16. Ebert D, Feistel H, Loew T, Pirner A (1996). Dopamine and depression-striatal dopamine D2 receptor SPECT before and after antidepressant therapy. Psychopharmacology 126:91-94.
17. Freeman EW, Frye CA, Rickels K, Martin PA, Smith SS (2002). Allopregnanolone levels and symptom improvement in severe premenstrual syndrome. J Clin Psychopharmacol 22:516-520.
18. Frye CA, Walf AA (2002). Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 41:306-315.
19. Frye CA, Walf AA (2004). Hippocampal 3alpha, 5alpha-THP may alter depressive behavior of pregnant and lactating rats. Pharmacol Biochem Behav 78:531-540.
20. Frye CA, Wawrzycki J (2003). Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Horm Behav 44:319-326.
21. Frye CA, Walf AA, Sumida K (2004). Progestins' actions in the VTA to facilitate lordosis involve dopamine-like type 1 and 2 receptors. Pharmacol Biochem Behav 78:405-418.
22. Gambarana C, Ghiglieri O, De Montis MG (1995a). Desensitization of the D1 dopamine receptors in rats reproduces a model of escape deficit reverted by imipramine, fluoxetine and clomipramine. Prog Neuropsychopharmacol Biol Psychiatry 19:741-755.
23. Gambarana C, Ghiglieri O, Tagliamonte A, D'Alessandro N, De Montis MG (1995b). Crucial role of D1 dopamine receptors in mediating the anti-depressant effect of imipramine. Pharmacol Biochem Behav 50:147-151.
24. Griffin LD, Mellon SH (1999). Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci U S A 96:13512-13517.
25. Hirani K, Khisti RT, Chopde CT (2002). Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3a-hydroxy-5a-pregnan-20-one. Neuro-pharmacology 43:1339-1350.
26. Jaworska-Feil L, Budziszewska B, Leskiewicz M, Lason W (2000). Effects of some centrally active drugs on the allopregnanolone synthesis in rat brain. Pol J Pharmacol 52:359-365.
27. Jenkins JA, Williams P, Kramer GL, Davis LL, Petty F (2001). The influence of gender and the estrous cycle on learned helplessness in the rat. Biol Psychol 58:147-158.
28. Khisti RT, Chopde CT (2000). Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20- one in mice. Brain Res 865:291-300.
29. Khisti RT, Chopde CT, Jain SP (2000). Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 67:137-143.
30. Klatzkin RR, Morrow AL, Light KC, Pedersen CA, Girdler SS (2006). Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women. Biol Psychol 7:2-11.
31. Klimke A, Larisch R, Janz A, Vosberg H, Müller-Gärtner HW, Gaebel W (1999). Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry Res 90:91-101.
32. Maj J, Rogoz Z, Skuza G, Sowinska H (1992). The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test. Pol J Pharmacol Pharm 44:337-346.
33. Marcondes FK, Bianchi FJ, Tanno AP (2002). Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 62:609-614.
34. Marvan ML, Chavez-Chavez L, Santana S (1996). Clomipramine modifies fluctuations of forced swimming immobility in different phases of the rat estrous cycle. Arch Med Res 27:83-86.
35. Marvan ML, Santana S, Chavez-Chavez L, Bertran M (1997). Inescapable shocks accentuate fluctuations of forced swimming immobility in different phases of the rat estrous cycle. Arch Med Res 28:369-372.
36. Millan MJ, Brocco M, Papp M, Serres F, La Rochelle CD, Sharp T, et al. (2004). S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole. J Pharmacol Exp Ther 309:936-950. (Pubitemid 38669679)
37. Molina-Hernandez M, Tellez-Alcantara NP, Garcia JP, Lopez JI, Jaramillo MT (2004). Synergistic interaction between ketoconazole and several antidepressant drugs with allopregnanolone treatments in ovariectomized Wistar rats forced to swim. Prog Neuropsychopharmacol Biol Psychiatry 28:1337-1345.
38. Molina-Hernandez M, Tellez-Alcantara NP, Garcia JP, Lopez JI, Jaramillo MT (2005). Antidepressant-like actions of intra-accumbens infusions of allo-pregnanolone in ovariectomized Wistar rats. Pharmacol Biochem Behav 80:401-409.
39. Nappi RE, Petraglia F, Luisi S, Polatti F, Farina C, Genazzani AR (2001). Serum allopregnanolone in women with postpartum blues. Obstet Gynecol 97:77-80.
40. Nechmad A, Maayan R, Spivak B, Ramadan E, Poyurovsky M, Weizman A (2003). Brain neurosteroid changes after paroxetine administration in mice. Eur Neuropsychopharmacol 13:327-332.
41. Nikulina EM, Skrinskaya JA, Popova NK (1991). Role of genotype and dopamine receptors in behaviour of inbred mice in a forced swimming test. Psychopharmacology 105:525-529.
42. Pare WP, Redei E (1993). Sex differences and stress response of WKY rats. Physiol Behav 54:1179-1185.
43. Pinna G, Costa E, Guidotti A (2006). Fluoxetine and norfluoxetine stereo-specifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology 186:362-372.
44. Pinna G, Costa E, Guidotti A (2009). SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol 9:24-30.
45. Pisu MG, Serra M (2004). Neurosteroids and neuroactive drugs in mental disorders. Life Sciences 74:3181-3197.
46. Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB (1997). Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90:709-714.
47. Romeo E, Strohle A, Spalletta G, Di Michele F, Hermann B, Holsboer F, et al. (1998). Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155:910-913.
48. Rouge-Pont F, Mayo W, Marinelli M, Gingras M, Le Moal M, Piazza PV (2002). The neurosteroid allopregnanolone increases dopamine release and dopa-minergic response to morphine in the rat nucleus accumbens. Eur J Neurosci 16:169-173.
49. Serra G, Collu M, D'Aquila PS, De Montis GM, Gessa GL (1990). Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressant. Brain Res 527:234-243.
50. Serra G, Collu M, D'Aquila PS, De Montis GM, Gessa GL (1991). Chronic imipramine reverses B-HT 920-induced hypomotility in rats. J Neural Transm 84:237-240.
51. Setnik B, De Souza FG, D'Almeida V, Nobrega JN (2004). Increased homocysteine levels associated with sex and stress in the learned helplessness model of depression. Pharmacol Biochem Behav 77:155-161.
52. Shimazu S, Minami A, Kusumoto H, Yoneda F (2005). Antidepressant-like effects of selegiline in the forced swim test. Eur Neuropsychopharmacol 15:563-571.
53. Sun MK, Alkon DL (2006). Differential gender-related vulnerability to depression induction and converging antidepressant responses in rats. J Pharmacol Exp Ther 316:926-932.
54. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A (1998). Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are r eceiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 95:3239-3244.
55. Uzunova V, Wrynn AS, Kinnunen A, Ceci M, Kohler C, Uzunov DP (2004). Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat. Eur J Pharmacol 486:31-34.
56. Uzunova V, Sampson L, Uzunov DP (2006). Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action. Psychopharmacology 186:351-361.
57. Vaugeois JM, Pouhe D, Zuccaro F, Costentin J (1996). Indirect dopamine agonist's effects on despair test: dissociation from hyperactivity. Pharmacol Biochem Behav 54:235-239.
58. Yamada J, Sugimoto Y, Yamada S (2004). Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur J Pharmacol 504:207-211.
59. Zimmerberg B, Brunelli SA, Fluty AJ, Frye CA (2005). Differences in affective behaviors and hippocampal allopregnanolone levels in adult rats of lines selectively bred for infantile vocalizations. Behav Brain Res 159:301-311.